GVIP logo

GVIPGoldman Sachs ETF Trust - Goldman Sachs Hedge IND VIP ETF

$174.54
$6.57
(3.63%)
Today
Updated: 01:38 PM EDT
Vol5,000.00
52W High$181.46
52W Low$131.18
News
all
press releases
News Placeholder
ABVX Stock Clocks Worst Day Ever On Malignancy Signal For Drug: ‘Pharma Bro’ Says ‘GLPs Are Doing Fine’ After Similar Fears
Shares of ABVX closed down 44% on Tuesday, clocking its worst day ever, on reports of a number of non-melanoma skin cancers and other malignancies observed in its ulcerative colitis trial.
Stocktwits
News Placeholder
ABVX Tanks 30% After-Hours Despite 51% Remission In Ulcerative Colitis Trial — Rare Cancer Concerns Hit Sentiment
The company dismissed the cancers observed in the trial as rare, occurring primarily in older patients, and largely unrelated to treatment.
Stocktwits
<
...
1
>

Advertisement|Remove ads.